In a recent development, kratom supporters are urging the U.S. Food and Drug Administration (FDA) to regulate the herbal supplement, which is primarily used for pain relief. Advocates argue that the FDA’s failure to regulate kratom has led to a lack of standardization and potential risks to consumers. The American Kratom Association recently issued a consumer advisory, calling for the FDA to:
- Publish manufacturing standards for kratom products.
- Remove kratom products that lack adequate labeling and recommended serving sizes.
The push for regulation comes in light of recent wrongful death lawsuits linked to kratom. Advocates insist that the problem lies not with the herbal supplement itself but with “bad actors” in the industry who produce unsafe products.
An estimated 2 million Americans use kratom, which is derived from an evergreen tree native to Southeast Asia. However, health experts, including the Mayo Clinic, have expressed concerns about its safety and potential side effects.
For more details, read the full article on WXII 12.
